Maria Gonzalez-Gomis
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Neuroprotective strategies for cognitive decline in type 2 diabetes.
Journal: Trends in endocrinology and metabolism: TEM
Published: February 09, 2026
Down Syndrome and Obesity Management: Lifestyle Observations Made in the Framework of the GO-DS21 Project and Clinical Recommendations.
Journal: Nutrients
Published: January 20, 2026
Dietary Patterns and Lifestyle Factors as Determinants of Body Mass Index and Body Composition in Individuals with Down Syndrome-A Study Across Three Clinical Sites.
Journal: Nutrients
Published: January 20, 2026
A multimodal lifestyle intervention complemented with epigallocatechin gallate to prevent cognitive decline in APOE- ɛ4 carriers with Subjective Cognitive Decline: a randomized, double-blinded clinical trial (PENSA study).
Journal: The journal of prevention of Alzheimer's disease
Published: May 23, 2025
Intensive assessment of executive functions derived from performance in cognitive training games.
Journal: iScience
Published: October 24, 2022
State-of-the-art therapy for Down syndrome.
Journal: Developmental medicine and child neurology
Published: September 09, 2022
Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase Ib clinical trial (PERSEUS study).
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: March 14, 2022
An Alternative Maze to Assess Novel Object Recognition in Mice.
Journal: Bio-protocol
Published: March 12, 2020
Protein Kinase C-Gamma Knockout Mice Show Impaired Hippocampal Short-Term Memory While Preserved Long-Term Memory.
Journal: Molecular neurobiology
Published: November 29, 2019
Use of the Vsoc-maze to Study Sociability and Preference for Social Novelty in Rodents.
Journal: Bio-protocol
Published: May 21, 2019
Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome.
Journal: Neurobiology of disease
Published: October 06, 2018
Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: February 14, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026